Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study

被引：65

作者：

Garey, Kevin W. ^{[1
,2
]}

Jiang, Zhi-Dong ^{[3
]}

Bellard, Angelle ^{[2
]}

DuPont, Herbert L. ^{[2
,3
,4
]}

机构：

[1] Univ Houston, Coll Pharm, Houston, TX 77030 USA

[2] St Lukes Episcopal Hosp, Houston, TX 77030 USA

[3] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA

[4] Baylor Coll Med, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL GASTROENTEROLOGY | 2009年 / 43卷 / 01期

关键词：

IN-VITRO ACTIVITY; VANCOMYCIN;

D O I：

10.1097/MCG.0b013e31814a4e97

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：91 / 93

页数：3

共 12 条

[1] Epidemiology of Clostridium difficile-associated infections [J].

Barbut, F ;

Petit, JC .

CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (08) :405-410

[2] COMPARISON OF 3 ENZYME IMMUNOASSAYS, A CYTOTOXICITY ASSAY, AND TOXIGENIC CULTURE FOR DIAGNOSIS OF CLOSTRIDIUM-DIFFICILE ASSOCIATED DIARRHEA [J].

BARBUT, F ;

KAJZER, C ;

PLANAS, N ;

PETIT, JC .

JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (04) :963-967

[3] DEVELOPMENT OF A RAPID AND EFFICIENT RESTRICTION-ENDONUCLEASE ANALYSIS TYPING SYSTEM FOR CLOSTRIDIUM-DIFFICILE AND CORRELATION WITH OTHER TYPING SYSTEMS [J].

CLABOTS, CR ;

JOHNSON, S ;

BETTIN, KM ;

MATHIE, PA ;

MULLIGAN, ME ;

SCHABERG, DR ;

PETERSON, LR ;

GERDING, DN .

JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (07) :1870-1875

[4] A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea [J].

DuPont, HL ;

Jiang, ZD ;

Okhuysen, PC ;

Ericsson, CD ;

de la Cabada, FJ ;

Ke, S ;

DuPont, MW ;

Martinez-Sandoval, F .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) :805-812

[5]

Gerard Laura, 2005, Expert Rev Anti Infect Ther, V3, P201, DOI 10.1586/14787210.3.2.201

[6] Enteroaggregative Escherichia coli Diarrhea in Travelers: Response to Rifaximin Therapy [J].

Infante, Rosa M. ;

Ericsson, Charles D. ;

Jiang, Zhi-Dong ;

Ke, Shi ;

Steffen, Robert ;

Riopel, Lise ;

Sack, David A. ;

DuPont, Herbert L. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (02) :135-138

[7] In vitro activity and fecal concentration of rifaximin after oral administration [J].

Jiang, ZD ;

Ke, S ;

Palazzini, E ;

Riopel, L ;

Dupont, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2205-2206

[8] Interruption of recurrent Clostridium difficile -: Associated diarrhea episodes by serial therapy with vancomycin and rifaximin [J].

Johnson, Stuart ;

Schriever, Christopher ;

Galang, Minerva ;

Kelly, Ciaran P. ;

Gerding, Dale N. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (06) :846-848

[9] In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species [J].

Marchese, A ;

Salerno, A ;

Pesce, A ;

Debbia, EA ;

Schito, GC .

CHEMOTHERAPY, 2000, 46 (04) :253-266

[10] Recurrent Clostridium difficile [J].

Maroo, S ;

Lamont, JT .

GASTROENTEROLOGY, 2006, 130 (04) :1311-1316

← 1 2 →